Ronald M. Kurtz M.D., President & CEO at RxSight, Inc. (RXST), sold 40,000 shares at $39.40 ($1.6M) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($1.6M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.40 | 20,000 | $788K | 49.6% |
| 2 | $40.01 | 20,000 | $800K | 50.4% |
| Total | $39.70 avg | 40,000 | $1.6M | 100% |
| Filing → |
| RXST | SELL | 2024-01-09 | $2.8M | — | Filing → |
| RXST | SELL | 2023-12-29 | $1.8M | — | Filing → |
| RXST | BUY | 2021-08-05 | $2.1M | — | Filing → |